Candriam Equities L Oncology Impact I
LU1864482515
Candriam Equities L Oncology Impact I/ LU1864482515 /
NAV 29.08.2024
Diff.+10,0999
Ertragstyp
Ausrichtung
Fondsgesellschaft
2.348,9700 GBP
+0,43%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in GBP
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.602,5200
+20,84%
+5,21%
Candriam Equities L Oncology Imp...
thesaurierend
2.781,9299
+20,99%
+5,60%
Candriam Equities L Oncology Imp...
thesaurierend
2.348,9700
+15,26%
+8,98%
Candriam Equities L Oncology Imp...
ausschüttend
1.745,0000
+20,45%
+4,20%
Candriam Equities L Oncology Imp...
ausschüttend
21.888,0000
+13,64%
-2,28%
Candriam Equities L Oncology Imp...
thesaurierend
2.277,5801
+18,04%
-3,19%
Candriam Equities L Oncology Imp...
thesaurierend
1.939,1700
+15,63%
-
Candriam Equities L Oncology Imp...
thesaurierend
223,4200
+16,93%
-5,89%
Candriam Equities L Oncology Imp...
thesaurierend
260,3000
+16,72%
+7,96%
Candriam Equities L Oncology Imp...
ausschüttend
255,2100
+19,32%
+1,32%
Candriam Equities L Oncology Imp...
ausschüttend
207,1400
+20,33%
+3,89%
Candriam Equities L Oncology Imp...
thesaurierend
166,1300
+15,13%
+8,61%
Candriam Equities L Oncology Imp...
thesaurierend
276,4600
+17,71%
+10,73%
Candriam Equities L Oncology Imp...
thesaurierend
222,6200
+16,46%
-7,00%
Candriam Equities L Oncology Imp...
thesaurierend
310,6000
+20,33%
+3,88%
Candriam Equities L Oncology Imp...
thesaurierend
209,2600
+17,99%
-
Candriam Equities L Oncology Imp...
thesaurierend
3.123,4500
+20,45%
+4,20%
Candriam Equities L Oncology Imp...
thesaurierend
167,1400
-
-
Candriam Equities L Oncology Imp...
thesaurierend
296,5000
+19,32%
+1,30%
Performance
lfd. Jahr
+14,06%
6 Monate
+7,22%
1 Jahr
+15,26%
3 Jahre
+8,98%
5 Jahre
-
10 Jahre
-
seit Beginn
+56,60%
Jahr
2023
-4,59%
2022
+1,72%
2021
+4,39%